GLP-1 (Glucagon-Like Peptide-1): Research, Uses, Side Effects, and Safety

Key takeaways

• GLP-1 medications mainly help manage blood sugar in type 2 diabetes, and some are also used for obesity.
• Common side effects are nausea, vomiting, stomach pain, diarrhea, constipation, and changes in appetite.
• FDA-approved products have gone through review for safety, effectiveness, and quality; compounded or unapproved versions have not.
• Injectable GLP-1 drugs need proper refrigeration, and patients should not use a product that arrives warm or with weak ice packs.

What GLP-1 is

GLP-1 stands for glucagon-like peptide-1. In medicine, the term usually refers to GLP-1 receptor agonists, a class of drugs that copy the action of a natural hormone made in the small intestine. This hormone helps regulate blood sugar, digestion, and appetite. When these medications are used in treatment plans, people may feel full sooner and eat less. Some people also lose weight because appetite drops and calorie intake falls.

These drugs are mainly used for type 2 diabetes. Some are also used for obesity. They are often given by injection under the skin. Common injection sites include the belly, outer thighs, upper buttocks, and backs of the arms. The first GLP-1 agonist approved by the FDA was exenatide in 2005. Research is still ongoing, and new uses and risks are still being studied.

Examples of drugs in this class

Examples named in the research include semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide. Tirzepatide is described as a dual GLP-1/GIP receptor agonist. Semaglutide appears in products such as Ozempic and Wegovy. Tirzepatide appears in Mounjaro and Zepbound.

If you want to compare related peptide medicine topics, see Semaglutide and Tirzepatide.

Why GLP-1 drugs are used

The main clinical role of GLP-1 drugs is glucose control in type 2 diabetes. They help trigger insulin release from the pancreas, which lowers blood sugar. They also affect appetite and digestion. Because of those effects, some GLP-1 drugs are used for obesity treatment too.

These medications are not complete treatment by themselves. The research notes that both type 2 diabetes and obesity still require other strategies, including lifestyle and dietary changes. That matters because GLP-1 therapy is usually part of a broader plan, not a standalone fix.

How they fit into care

The drugs are often used when blood sugar, body weight, or both need support. The choice of medicine, dose, and form depends on the treatment plan. The research also notes that there are no generic versions available to date, which can affect access and cost.

Common side effects

GI side effects are the most common problems reported with GLP-1 drugs. Across clinical trials, nausea and diarrhea were very common. Vomiting, constipation, abdominal pain, and dyspepsia were also reported. These effects often show up early in treatment and tend to ease over time.

Nausea is the most common adverse effect. One review reports that up to 50% of patients may be affected. Most episodes are mild to moderate and often get better with ongoing use. Some studies also found that slower gastric emptying may help explain why nausea happens. In one clinical trial, exenatide twice-daily slowed gastric emptying more than exenatide once-weekly.

What patients may notice

People may notice reduced appetite, stomach upset, diarrhea, constipation, or belly pain. One source also describes appetite changes as a common side effect. Because these symptoms can affect daily eating, hydration, and medication tolerance, patients often need practical guidance from a clinician to stay on therapy.

Safety concerns and product quality

The FDA has raised concerns about unapproved GLP-1 drugs used for weight loss. The agency says unapproved versions do not go through FDA review for safety, effectiveness, or quality before they are marketed. The FDA also states that compounded drugs should only be used when a patient’s medical need cannot be met by an FDA-approved drug.

A key safety issue is storage during shipping. Injectable GLP-1 drugs require refrigeration as directed in their package inserts. The FDA has received complaints about compounded GLP-1 products arriving warm or with too little ice to keep them at the right temperature. The agency recommends not using any injectable GLP-1 drug that arrives warm or without enough refrigeration, because quality can be affected.

What this means in practice

Patients should get a prescription from a doctor and fill it at a state-licensed pharmacy. The FDA also points people to its BeSafeRx resources for buying prescription medicines online. If there are questions about a medicine, the FDA advises talking to a doctor.

Muscle, body composition, and weight loss questions

One topic that comes up often is body composition. The research bundle includes claims from commercial sources and commentary that some weight loss may come from muscle. It also includes discussion of lean mass loss and muscle loss concerns. However, the strongest supported point in the provided material is narrower: weight loss with GLP-1 therapy can raise questions about muscle preservation, and nutrition strategy matters when appetite drops.

One commercial source says appetite can become so low that it is hard to eat enough protein, and it recommends a protein-focused support stack. Another source says people may need to plan nutrition carefully to support muscle preservation and recovery. Because those claims come from marketing material, they should be treated as recommendations from that source, not as broad clinical proof.

Practical nutrition angle

If appetite is reduced, getting enough protein may be harder. That can make meal planning more important during treatment. The research material supports the idea that nutrition and exercise remain relevant while taking GLP-1 drugs, even when weight loss is the main goal.

How researchers and patients should think about GLP-1 use

GLP-1 drugs sit at the intersection of endocrinology, obesity care, and patient safety. On the benefit side, they help with blood sugar control and can support weight loss. On the risk side, they commonly cause gastrointestinal symptoms, and the quality of the product matters a great deal.

For research-minded readers, the most important distinction is between FDA-approved products and unapproved or compounded versions. The approved path includes regulatory review. The unapproved path does not. That difference matters even when the active ingredient sounds familiar. It also matters because storage problems during shipping can change product quality before the medication ever reaches the patient.

For clinicians and self-experimenters alike, the research points to a simple standard: use approved products when possible, watch for GI side effects early in treatment, and treat refrigeration and source quality as core safety issues, not minor details.

FAQ

What does GLP-1 mean?

GLP-1 means glucagon-like peptide-1. In the medical setting, it usually refers to a class of drugs called GLP-1 receptor agonists. These drugs mimic a natural hormone involved in blood sugar control, digestion, and appetite.

What are GLP-1 drugs used for?

They are mainly used to manage blood sugar in people with type 2 diabetes. Some GLP-1 drugs are also used for obesity. The research notes that they are part of a larger treatment plan that still includes lifestyle and dietary changes.

What side effects are most common?

The most common side effects are nausea and diarrhea. Vomiting, constipation, abdominal pain, dyspepsia, and appetite changes are also reported. These problems are often worse at the start and may improve with time.

Are compounded GLP-1 products safe?

The FDA says compounded or unapproved GLP-1 products are not FDA approved and are not reviewed for safety, effectiveness, or quality before marketing. The agency says compounded drugs should be used only when a patient’s need cannot be met by an FDA-approved drug.

What should I do if a GLP-1 injection arrives warm?

The FDA advises not to use an injectable GLP-1 drug that arrives warm or with too little ice to keep it at the recommended temperature. Because refrigeration affects quality, patients should contact the pharmacy or prescriber before using the product.